Ambroxol acefyllinate is a medicinal product that, when administered orally, is absorbed into the gastrointestinal tract, providing blood levels of 7-theophylline acetic acid and ambroxol. This property justifies its dual antiinflammatory action and its favourable action on bronchial secretions.
The antiinflammatory action takes place by increasing the cyclic AMP content in the bronchial tracheal musculature.
As well as modifying the rheological properties of the mucus, ambroxol acefyllinate increases both “in vitro” and “in vivo” mucociliary clearance.
SURFOLASE is therefore able to act on different pathogenetic factors which lead to obstruction of the bronchi.
Bronchodilator in symptomatic treatment of bronchopulmonary illnesses with spastic bronchial component.
Last update: September 16, 2015 at 03:04 PM